Seoul, South Korea, and Berlin, Germany – (July 12, 2022) – LegoChem Biosciences Inc. (LCB) and Glycotope GmbH (Glycotope) have signed a Research Collaboration and License Agreement to develop an antibody drug conjugate (ADC) by combining LCB’s…
Two presentations at LINC 2022 focus on the performance of BIOTRONIK’s drug-coated balloon as a standalone therapy or combined with selective stenting following suboptimal angioplasty in challenging femoropopliteal lesions
Berlin, 6 July 2022. Eckert & Ziegler (ISIN DE0005659700, SDAX) has signed an agreement with the U.S. pharmaceutical company Ratio Therapeutics Inc. for the joint development and manufacture of innovative radiopharmaceutical products based on Lu-177…
Medical students: Charité most popular as an employer
In modern society, the incidence of neurodegenerative diseases such as Alzheimer's and Parkinson's is steadily increasing. Emerging symptoms range from memory and movement disorders to the inability to lead a self-determined life. These changes place…
A cellulose based material could be useful for medical applications such as wound sealant
HONOURING LIFE-TIME ACHIEVEMENTS TOWARDS HEALTH FOR ALL
Hein to lead as SCIENION plans for long-term profitable growth
EPO has been founded in 1997 as a spin-off from the Max-Delbrück-Center for Molecular Medicine [MDC] in Berlin Buch and is celebrating its 25th business anniversary this year. Since 1997 EPO has grown steadily and today has a loyal customer base of…
BERLIN, BOSTON, REYKJAVIK, 05 May 2022 – International digital therapeutics leader Sidekick Health (www.sidekickhealth.com) today announces that it has raised $55 million in Series B funding. The round was led by London-based venture capital firm N…
